De Ponti F, Drug development for the irritable bowel syndrome: current challenges and future perspectives., «FRONTIERS IN PHARMACOLOGY», 2013, 4, Article number: 7 , pp. 1 - 12 [Scientific article]Open Access
Fabrizio De Ponti, Global Perspectives in Pharmacovigilance, «JOURNAL OF PHARMACOVIGILANCE», 2013, 01, pp. 1 - 2 [Comment or similar]
Emanuel Raschi; Elisabetta Poluzzi; Ariola Koci; Ugo Moretti; Miriam Sturkenboom; Fabrizio De Ponti, Macrolides and Torsadogenic Risk: Emerging Issues from the FDA Pharmacovigilance Database, «JOURNAL OF PHARMACOVIGILANCE», 2013, 01, pp. 1 - 4 [Scientific article]
Raschi E.; Piccinni C.; Poluzzi E.; Marchesini G.; De Ponti F., The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database., «ACTA DIABETOLOGICA», 2013, 50, pp. 569 - 577 [Scientific article]
Raschi E;Poluzzi E;Godman B;Koci A;Moretti U;Kalaba M;Bennie M;Barbui C;Wettermark B;Sturkenboom M;De Ponti F, Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe., «PLOS ONE», 2013, 8, pp. 1 - 14 [Scientific article]Open Access
Poluzzi E; Piccinni C; Sangiorgi E; Clo M; Tarricone I; Menchetti M; De Ponti F, Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2013, 69, pp. 2095 - 2101 [Scientific article]
Piccinni C; Raschi E; Poluzzi E; Puccini A; Cars T; Wettermark B; Diemberger I; Boriani G; De Ponti F., Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden., «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2013, 69, pp. 715 - 720 [Scientific article]
C. Piccinni; E. Poluzzi; E. Raschi; B. Vitamia; A. Koci; F. De Ponti, Use and Perception of Phytoestrogens
in Postmenopausal Women: Result
of a Questionnaire-Based Survey, in: ABSTRACTS, Adis, «DRUG SAFETY», 2013, pp. 867 - 868 (atti di: 13th ISoP Annual Meeting: ‘‘The Renaissance of Pharmacovigilance’’, Pisa, 01-04/10/2014) [Poster]
Mariam Molokhia;Fabrizio De Ponti;Elijah R Behr;Gianluca Trifirò;Miriam Sturkenboom, Academic output from EU-funded health research projects, «THE LANCET», 2012, 380, pp. 1903 - 1904 [Comment or similar]
Raschi E.; De Ponti F., Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology., «INTERNAL AND EMERGENCY MEDICINE», 2012, 7, pp. 113 - 131 [Scientific article]
B. Balestra;R. Vicini;C. Cremon;L. Zecchi;G. Dothel;V. Vasina;R. De Giorgio;A. Paccapelo;O. Pastoris;V. Stanghellini;R. Corinaldesi;F. De Ponti;M. Tonini;G. Barbara, Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons, «NEUROGASTROENTEROLOGY AND MOTILITY», 2012, 24, pp. 1118 - 1125 [Scientific article]
Elisabetta Poluzzi; Emanuel Raschi; Carlo Piccinni; Fabrizio De Ponti, Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS), in: Data Mining Applications in Engineering and Medicine, RIJEKA, InTech, 2012, pp. 265 - 302 [Chapter or essay]
Sacripanti C; Piccinni C; Poluzzi E; De Ponti F, Drug-related Progressive Multifocal Leukoencephalopathy (PML): datamining of FDA_AERS (Adverse Event Reporting System), in: ABSTRACTS, Wiley Blackewell, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2012, 21, pp. 43 - 43 (atti di: 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Barcelona, August 23-26, 2012) [Abstract]
Piccinni C; Raschi E; Poluzzi E; Puccini A; Cars T; Wettermark B; Diemberger I; Boriani G; De Ponti F, Impact of dronedarone authorisation on antiarrhythmic utilisation: interrupted time series strategy on Italian and Swedish prescription databases, in: Abstracts, 2012, pp. 1 - 1 (atti di: XVI Seminario Nazionale Dottorandi e Assegnisti in Farmacologia ed affini, Rimini, 16-19 settembre 2012) [Abstract]
Piccinni C; Raschi E; Poluzzi E; Puccini A; Cars T; Wettermark B; Diemberger I; Boriani G; De Ponti F., Interrupted time series analysis on the impact of dronedarone authorisation on Italian and Swedish antiarrhythmic prescriptions, in: ABSTRACTS, Wiley Blackewell, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2012, 21, pp. 290 - 291 (atti di: 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Barcelona, August 23-26, 2012) [Abstract]
